Home > Healthcare > Medical Devices > Diagnostic Devices > Dermal Toxicity Testing Market
Dermal Toxicity Testing Market size was valued at USD 2.1 billion in 2022 and is anticipated to grow at a CAGR of around 8.3% between 2023 and 2032. Dermal toxicity testing is a type of safety assessment conducted to evaluate the potential harmful effects of a substance when it comes into contact with the skin.
The goal of dermal toxicity testing is to determine the adverse effects a substance may have on the skin, including irritation, sensitization, and other forms of damage. As per Allergy and Asthma Network Organization of U.S., currently more than 50 million Americans are suffering from one or other kind of allergy. Such rising number of allergy cases is said to increase the demand for dermal toxicity testing.
Additionally, there is a growing recognition of the ethical concerns associated with the use of animals in testing procedures. Several organizations advocate for the reduction and replacement of animal testing due to concerns about the welfare and treatment of animals. Such aforementioned factors will boost industry growth during forecast period.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Dermal Toxicity Testing Market Size in 2022: | USD 2.1 Billion |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 8.3% |
2032 Value Projection: | USD 4.5 Billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 275 |
Tables, Charts & Figures: | 360 |
Segments covered: | Type, Testing Method, Test Type, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|